Literature DB >> 20203241

Pandemic 2009 influenza A in Argentina: a study of 337 patients on mechanical ventilation.

Elisa Estenssoro1, Fernando G Ríos, Carlos Apezteguía, Rosa Reina, Jorge Neira, Daniel H Ceraso, Cristina Orlandi, Ricardo Valentini, Norberto Tiribelli, Matías Brizuela, Carina Balasini, Sebastián Mare, Gustavo Domeniconi, Santiago Ilutovich, Alejandro Gómez, Javiera Giuliani, Cecilia Barrios, Pascual Valdez.   

Abstract

RATIONALE: The rapid spread of the 2009 Influenza A (H1N1) around the world underscores the need for a better knowledge of epidemiology, clinical features, outcomes, and mortality predictors, especially in the most severe presentations.
OBJECTIVES: To describe these characteristics in patients with confirmed, probable, and suspected viral pneumonia caused by 2009 influenza A (H1N1) admitted to 35 intensive care units with acute respiratory failure requiring mechanical ventilation in Argentina, between June 3 and September 7.
METHODS: Inception-cohort study including 337 consecutive adult patients. Data were collected in a form posted on the Argentinian Society of Intensive Care website.
MEASUREMENTS AND MAIN RESULTS: Proportions of confirmed, probable, or suspected cases were 39%, 8%, and 53% and had similar outcomes. APACHE II was 18 +/- 7; age 47 +/- 17 years; 56% were male; and 64% had underlying conditions, with obesity (24%), chronic obstructive respiratory disease (18%), and immunosupression (15%) being the most common. Seven percent were pregnant. On admission, patients had severe hypoxemia (Pa(O(2))/Fi(O(2)) 140 [87-200]), extensive lung radiologic infiltrates (2.87 +/- 1.03 quadrants) and bacterial coinfection, (25%; mostly with Streptococcus pneumoniae). Use of adjuvants such as recruitment maneuvers (40%) and prone positioning (13%), and shock (72%) and acute kidney injury requiring hemodialysis (17%), were frequent. Mortality was 46%, and was similar across all ages. APACHE II, lowest Pa(O(2))/Fi(O(2)), shock, hemodialysis, prone positioning, and S. pneumoniae coinfection independently predicted death.
CONCLUSIONS: Patients with 2009 influenza A (H1N1) requiring mechanical ventilation were mostly middle-aged adults, often with comorbidities, and frequently developed severe acute respiratory distress syndrome and multiorgan failure requiring advanced organ support. Case fatality rate was accordingly high.

Entities:  

Mesh:

Year:  2010        PMID: 20203241     DOI: 10.1164/201001-0037OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  84 in total

1.  Critically ill children during the 2009-2010 influenza pandemic in the United States.

Authors:  Adrienne G Randolph; Frances Vaughn; Ryan Sullivan; Lewis Rubinson; B Taylor Thompson; Grace Yoon; Elizabeth Smoot; Todd W Rice; Laura L Loftis; Mark Helfaer; Allan Doctor; Matthew Paden; Heidi Flori; Christopher Babbitt; Ana Lia Graciano; Rainer Gedeit; Ronald C Sanders; John S Giuliano; Jerry Zimmerman; Timothy M Uyeki
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

2.  PB1-F2 modulates early host responses but does not affect the pathogenesis of H1N1 seasonal influenza virus.

Authors:  Isabelle Meunier; Veronika von Messling
Journal:  J Virol       Date:  2012-02-08       Impact factor: 5.103

Review 3.  Antivirals for influenza: a summary of a systematic review and meta-analysis of observational studies.

Authors:  Nancy Santesso; Jonathan Hsu; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Influenza Other Respir Viruses       Date:  2013-09       Impact factor: 4.380

4.  Con: corticosteroids are not indicated for treatment of acute lung injury from H1N1 viral pneumonia.

Authors:  Michael A Matthay; Kathleen D Liu
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

Review 5.  Update in acute lung injury and critical care 2010.

Authors:  István Vadász; Jacob I Sznajder
Journal:  Am J Respir Crit Care Med       Date:  2011-05-01       Impact factor: 21.405

Review 6.  Antivirals for treatment of influenza: a systematic review and meta-analysis of observational studies.

Authors:  Jonathan Hsu; Nancy Santesso; Reem Mustafa; Jan Brozek; Yao Long Chen; Jessica P Hopkins; Adrienne Cheung; Gayane Hovhannisyan; Liudmila Ivanova; Signe A Flottorp; Ingvil Saeterdal; Arthur D Wong; Jinhui Tian; Timothy M Uyeki; Elie A Akl; Pablo Alonso-Coello; Fiona Smaill; Holger J Schünemann
Journal:  Ann Intern Med       Date:  2012-02-27       Impact factor: 25.391

Review 7.  The co-pathogenesis of influenza viruses with bacteria in the lung.

Authors:  Jonathan A McCullers
Journal:  Nat Rev Microbiol       Date:  2014-03-03       Impact factor: 60.633

8.  Genetic discovery, rigorous statistics, and pandemic influenza.

Authors:  Mary Beth Scholand; Theodore G Liou
Journal:  Chest       Date:  2014-06       Impact factor: 9.410

Review 9.  Official ERS/ATS clinical practice guidelines: noninvasive ventilation for acute respiratory failure.

Authors:  Bram Rochwerg; Laurent Brochard; Mark W Elliott; Dean Hess; Nicholas S Hill; Stefano Nava; Paolo Navalesi; Massimo Antonelli; Jan Brozek; Giorgio Conti; Miquel Ferrer; Kalpalatha Guntupalli; Samir Jaber; Sean Keenan; Jordi Mancebo; Sangeeta Mehta; Suhail Raoof
Journal:  Eur Respir J       Date:  2017-08-31       Impact factor: 16.671

10.  Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May-September 2009).

Authors:  J S Nguyen-Van-Tam; P J M Openshaw; A Hashim; E M Gadd; W S Lim; M G Semple; R C Read; B L Taylor; S J Brett; J McMenamin; J E Enstone; C Armstrong; K G Nicholson
Journal:  Thorax       Date:  2010-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.